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NK cells are a heterogeneous group of lymphocytes operationally defined by
their ability to lyse, without prior sensitization, specific tumorand virally infected
cells (1) . In addition to the role ofNK in infection and tumor surveillance, these
cells probably have an important function in the regulation of lymphocyte
proliferation by means of suppression of dendritic cells that have interacted with
antigens (2-4) . The liver is the major organ responsible for the clearance and
degradation of antigens . Because the liver provides a rich source of NK (5) and
multiple abnormalities in immune regulation have been reported in murine
lupus, we have examined NK activity of freshly isolated, unstimulated hepatic
nonparenchymal cells (NPC) from MRL/lprand (NZB X NZW)F I mice . We have
found remarkably high levels of NK activity in the liver of these autoimmune
strains that are not reflected in the spleen or peripheral blood .
Materials and Methods
Mice .
￿
C3H/HeN, BALB/c, and DBA/2J female mice, 1-8 mo old, were purchased
from TheJackson Laboratory, Bar Harbor, ME . (NZBx NZW)F,, 1-8mo old, MRL/MpJ-
lpr/lpr (MRL/lpr) and MRL/Mpj-+/+ (MRL+/+) female mice, 0.5-4.5 mo old, were
obtained from colonies maintained at the National Institutes of Health, Bethesda, MD or
from The Jackson Laboratories .
Irradiation .
￿
Cells were irradiated from a "'Cs source at a rate of 170 rad/min .
Reagents and Cells. Collagenase IV and Metrizamide were purchased from Sigma
Chemical Co ., St . Louis, MO . Corynebacterium parvum was purchased from Burroughs
Wellcome Co ., Research Triangle Park, NC ; 1 .4 mg was injected intravenously 1-7 d
before killing. Polyinosinic-polycytidylic acid (poly I:C) was purchased from Sigma Chem-
ical Co . ; 100 Ag was injected intraperitoneally 24 h before killing. A mixture oflyophilized
mouse IFN-a and IFN-,B derived from cultures of mouse L929 cells stimulated with
poly(I:C) was purchased from Lee Biomolecular Research Laboratories, Inc ., San Diego,
CA ; 25,000 U were injected intraperitoneally 18 h before mice were killed .
Anti-asialo GM, antiserum (anti-AGM,) was purchased from Wako Pure Chemical
Industries, Ltd ., Osaka, Japan . Monoclonal anti-Thy-1, rat antibody designated AT83A,
was a generous gift ofDr . FrankW . Fitch, The University of Chicago, Chicago, IL . Anti-
Ly-1 .1 and anti-Ly-2.1 mAbs and low-tox-M rabbit complement (C') were purchased from
Accurate Chemical & Scientific Corp ., Westbury, NY . 10' cells/ml suspended in RPMI
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1640 (M.A. Bioproducts, Walkersville, MD) without FCS were treated with anti-AGM, at
a final dilution of 1 :100, anti-Thy-I (1 :10), anti-Ly-1 .1 (1 :20), or anti-Ly-2.1 (1 :20) plus
complement (1 :10) for 1 h at 37 ° C; cells were washed twice after treatment. YAC-1 cells,
originally derived from a Moloney virus-induced lymphoma in an A/Sn mouse and used
widely to assay cytotoxicity of murine NK cells (6) were grown continuously.
Hepatic NPC Isolation. Under sterile conditions, NPC were purified as previously
described (7) by collagenase perfusion of the portal vein and Metrizamide density centrif-
ugation. Total recovery ranged from 2-8 X 106 NPC per liver. Contamination by
hepatocytes, as determined by counting 200 cells from the preparation, was <1%. In
selected experiments the NPC were adhered to 100-mm Petri dish (No. 3003 ; Falcon
Labware, Oxnard, CA) for 90 min at 37° C (5% C02, 100% humidity) or treated with
carbonyl iron particles by mixing 107 NPCs in 10 ml RPMI 1640 plus 5% FCS with 100
mg of carbonyl iron particles. The mixture was poured into 100-mm Petri dish. After
incubation for 1 h at 37 °C, the carbonyl iron particles were moved to one side of the dish
with the magnet; and the nonadherent cells were then washed twice with fresh medium.
Spleen Cells and Peripheral Blood Leukocytes (PBL).
￿
Spleen cell suspensions were pre-
pared by gently pressing spleen through a 150-mesh stainless steel sieve into RPMI 1640
plus 10% FCS followed by gravity sedimentation. PBL were obtained by phlebotomy of
the retro-orbital plexus. Spleen cells and PBL were each separated on Ficoll-Hypaque
gradients, washed twice, and resuspended in RPMI 1640 plus 10% FCS.
AssayforNK Activity.
￿
YAC-1 target cells (106/100 Al) were labeled with 100 ACi 5 'Cr
(New England Nuclear, Boston, MA) during 1 h of incubation at 37 ° C in 5% C02. After
incubation the labeled YAC-I cells were washed three times and resuspended in RPMI
1640 medium with 10% FCS. NPC in 100 Pl RPMI plus 10% FCS were serially diluted
in V-bottomed 96-well microtiter trays (Dynatech Laboratories, Inc., Alexandria, VA)
and mixed with 5 X 10' 5'Cr-labeled YAC-I cells in 100 j.l medium . Plates were spun at
650g for 3 min. After a 4-h incubation at 37 °C, 100 jl ofeach supernatant were measured
for radioactivity with a gamma counter. The percent lysis was calculated using the
following formula: specific lysis = 100 X [(experimental release - spontaneous re-
lease)/(maximum release - spontaneous release)]. Spontaneous release was always <15%
of the maximum release. Maximum release was calculated by mixing 50 Al 5'Cr-labeled
target cells with 150 p1 of a 1 :20 dilution of Hematall LA lysing agent (Fisher Scientific
Co., Itasca, IL) and then multiplying the count by two. Maximum release was 100% of
the incorporated count. Experimental release was the average of duplicate assays.
Results
High Hepatic NK Cell Activity in MRL/lpr and (NZB X NZW)FI Mice.
￿
Hepatic
NPC NK cell activity, as measured by cytotoxicity to "Cr-labeled YAC-1 target
cells after a 4-h incubation, was always <16% lysis at an E/T ratio of 50:1 in
C3H/HeN, BALB/c, DBA/2J, and MRL+/+ female mice at all ages examined
and in MRL/lpr female mice <8 wk old. In MRL/lpr mice >8 wk old, cytotoxicity
increased from 37% (age 10 wk) to 63% (age 18 wk) (Fig. IA). In (NZB X
NZW)F, mice <3 mo old, NK activity in the younger mice was similar to the
nonautoimmune strains; however, the older mice (>3.5 mo) had higher NK
activity (Fig. 1 B).
NK Cell Activity: Comparison ofLiver, Spleen, and Peripheral Blood.
￿
The mark-
edly high NK cell activity of the liver in MRL/lpr mice was not found in the
spleen or peripheral blood mononuclear cells isolated from the same animals
(Fig. 2). In fact, the splenic NK activity of 4-mo-old MRL/lpr mice was slightly
lower than C3H/HeN mice of the same age. However, this latter observation
may be secondary to a dilutional effect; i.e., an increased number of Thy-1',
L3T4-, Ly2- lymphocytes (8).
Characteristics ofHepatic NK Cells in MRL/lpr Mice.
￿
The population of NPCN
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FIGURE 1 .
￿
HepaticNK cell activity assayed by cytotoxicity against "Cr-labeledYAC-I target
cells . (A) High NK activity noted in 2-mo (0) and 4-rno (O) MRL/Ipr female mice as opposed
to 2-mo (/) and 4-mo (p) MRL/++, and 3-mo-old C3H/HeN (A) female mice. (B) High
hepatic NK activity also noted in older (NZB X NZW)F, mice at 3.5 mo (O) and 6.5 mo (O),
but not at 2.5 mo (") . (A) NPC from C3H/HeN mice at 4 mo .
FIGURE 2 . High NK activity in liver of 4-mo-old
MRL/lpr female mice (0) is not reflected in the spleen
(/) or peripheral blood (A) . Neither the liver (O),
spleen (p), nor peripheral blood (A) of 4 moMRL/++
have high NK activity .
that demonstrated cytotoxicity to YAC-1 targets was found to be resistant to
irradiation (Fig . 3A) and not removed by adherence to plastic or carbonyl iron
particles (Fig . 3B) . 14-18% of the NPC were AGMI' as determined by FACS
analysis. The nonadherent cell population contained <3% macrophages (as
measured by phagocytosis of latex beads or positive staining for nonspecific
esterase), 25% large granular lymphocytes, and 25-40% large agranular lym-d
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￿
Characterization of hepatic NK cells assayed for cytotoxicity against "Cr-labeled
YAC-1 target cells . (A) A nonadherent NPC population accounts for the high NK activity in
MRL/Ipr mice . 4-mo-old female MRL/Ipr NPC were depleted ofadherent cells by adherence
to plastic (O) or carbonyl Fe treatment (Q) . Untreated NPC from 4-mo-old MRL/Ipr (l) and
MRL/++ (ti) female mice were controls. (B) The NPC population with high NK activity is
radioresistant . 2.5-mo-old female MRL/Ipr were irradiated with 600rad (O) or untreated (0)
18 h before harvesting NPC . (C) Hepatic NK in MRL/Ipr mice are AGM,* Ly-1- , andLy-2- .
NPC in medium only (/), anti-Ly-1 plus C' (p), and anti Ly-2 plus C' (O) retain high NK
activity . Anti Thy-1 + C' (A) partially and anti AGM, + C' (0) almost completely abolish NK
activity .
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￿
Effect of biologic response modifiers on hepatic NK
activity. 1 .4 mg C . parvum injected intravenously 24 h before
isolation of NPC-augmented NK activity in not only 4-mo-old
C3H/HeN (t1) (O, untreated) and 4-mo-old MRL/++ (A) (A, un-
treated),but also 4-mo-old MRL/Iprfemale mice (/) (p, untreated) .
phocytes . In vitro treatment with anti-AGM, and complement eradicated NK
activity . Although a mild decrease was noted after treatment with anti-Thy-1
and complement, anti-Lyl and/or anti-Ly2 and complement did not reduce NK
activity (Fig . 3C) .MAGILAVY ET AL.
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Hepatic NK Cell Activity: Effect ofBiologic Response Modifiers.
￿
A single injection
of C. parvum (1.4 mg i.v. 1-20 d before killed) augmented hepatic and splenic
NK activity in nonautoimmune mice (Fig. 4). Despite high hepatic NK activity
in the untreated MRL/lpr mouse, further enhancement was also noted with C.
parvum (Fig. 4). Intraperitoneal injection of poly(I :C) and IFN-a/ß also resulted
in increased NK activity in the MRL/lpr and nonautoimmune strains. A similar
response to C. parvum was noted in the (NZB x NZW)F, female mice, although
less change was noted in the older (6.5-mo-old) mice (data not shown).
Discussion
This paper provides evidence for extremely high hepatic natural killer cell
activity intheautoimmune MRL/lprand (NZB X NZW)Fi female mice. Although
more extreme in the MRL/lpr mice, hepatic NK activity increases with age in
bothstrainsand is elevatedbefore thedevelopmentofautoantibodies or evidence
ofclinical disease. Moreover, this marked elevation in these autoimmune strains
is not reflected in the spleen or peripheral blood. As is the case with the
nonautoimmune strains (5), NK activity can be further augmented by in vivo
administration of C. parvum, poly(I:C), and IFN-a/ß.
Preliminary characterization ofthese hepatic NK cells indicates no differences
from those isolated from the nonautoimmune strains. They are AGM1+, Ly-1-,
and Ly-2-, radioresistant, nonadherent, and not removed by carbonyl iron. The
fact that anti-Thy + C' treatment of NPC decreases, but does not eradicate,
cytotoxicity to YAC-1 cells suggests that hepatic NK represent a heterogeneous
population of cells.
The role that high hepatic NK activity may play in the autoimmune process is
conjectural. Our findings may only reflect the sequelae of endogenous Kupffer
cell activation of MRL/lpr and (NZB x NZW)F, mice (9) and, therefore, have
no functional significance per se. However, activated splenic NK have been
shown (4) to regulate T lymphocyte proliferation, as measured by MLR, by
eliminatingaccessorycellsthathavecombinedwith antigen. Moreover, decreased
allogeneic MLR responses, using spleen and lymph node cells from older
MRL/lprmiceasstimulators, havebeenreported (10). Indeed, we have observed
a markedly diminished allogeneic MLR using adherent hepatic NPC from both
young and old MRL/lpr mice as stimulators (Magilavy, D. B., and S. L. Latta,
manuscript in preparation).
This finding of high hepatic NK activity in these autoimmune strains appears
to conflict with numerous reports of defective or diminished NK activity of
peripheral blood from patients with active rheumatoid arthritis or systemic lupus
erythematosus (11, 12). However, the striking compartmental differences in NK
activity among the liver, spleen, and peripheral blood of the MRL/lpr mice that
we observed may explain the paradox. There are clearly differences among not
only the percentage of NK cells in the liver, spleen, and peripheral blood but
also the microenvironment of these organs. Because the liver is the major organ
responsible for the clearance of soluble IgG immune complexes and foreign
antigens, it would not be surprising that hepatic NK from the autoimmune mice
are selectively exposed to several secretory products which would result in either
activation or recruitment to the liver of NK from other organs.276
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Summary
This study demonstrates a profound elevation of NK activity, as measured by
cytotoxicity to YAC-1 targets in a 4-h incubation "Cr-release assay, of freshly
isolated hepatic NPC from both MRL/lpr and (NZB X NZW)F1 mice. This
marked increase was not observed in splenic or peripheral blood NK. The
hepatic NK were nonadherent, radioresistant, Ly-1-,2-, and AGM 1 +. Further-
more, biologic response modifiers can further augment hepatic NK activity in
these autoimmune strains.
We gratefully acknowledge Dr. Donald Rowley for his suggestions and critical review of
the manuscript.
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